Ryan M, Yule B, Bond C, Taylor R J
Department of Community Medicine, University of Aberdeen, Foresterhill.
BMJ. 1990 May 19;300(6735):1316-8. doi: 10.1136/bmj.300.6735.1316.
The government's proposal to introduce drug budgets will compel general practitioners to consider the financial consequences of prescribing. A survey was carried out of general practitioner principals in Grampian and a sample elsewhere in Scotland to examine their attitudes towards considering costs when prescribing and assess the accuracy of their knowledge of drug costs. Most general practitioners agreed that costs should be borne in mind when choosing medicines but their knowledge of drug costs was often inaccurate. Only one third of estimates were correct to within 25% of the actual cost, and there was a tendency to overstate the cost of cheap drugs and understate the cost of expensive ones. Some general practitioners were not aware of the relative prices of competing products or proprietary products and generic equivalents. The findings highlight the importance of providing general practitioners with readily accessible and up to date information on drug costs if prescribing budgets are to work.
政府引入药品预算的提议将迫使全科医生考虑开药的财务后果。对格兰扁地区的全科医生负责人以及苏格兰其他地区的一个样本进行了一项调查,以研究他们在开药时考虑成本的态度,并评估他们对药品成本知识的准确性。大多数全科医生同意在选择药物时应考虑成本,但他们对药品成本的了解往往不准确。只有三分之一的估计在实际成本的25%以内是正确的,而且存在高估廉价药品成本和低估昂贵药品成本的趋势。一些全科医生不知道竞争产品或专利产品与通用等效产品的相对价格。研究结果凸显了如果开药预算要发挥作用,就必须为全科医生提供易于获取且最新的药品成本信息的重要性。